Full Breakdown
WHO Member States Extend Pathogen-Sharing Talks, Delaying Pandemic Treaty
5/2/2026, 5:20:52 AM
Extended Negotiations on PABS Annex Delay Treaty Activation
On 1 May 2026 WHO member states extended talks on the Pathogen Access and Benefit-Sharing (PABS) annex. The unresolved annex, which would govern rapid pathogen data sharing and equitable vaccine access, blocks the Pandemic Agreement adopted in May 2025 from taking effect.
Pandemic Agreement and the Role of the PABS Annex
The Pandemic Agreement, adopted by the World Health Assembly in May 2025, seeks to improve global pandemic prevention, preparedness and response. Its activation hinges on the PABS annex, which would ensure swift genome sharing and fair distribution of medical countermeasures.
Key Participants and Negotiating Parties
Key participants are WHO Director-General Tedros Adhanom Ghebreyesus, WHO epidemic-preparedness lead Maria Van Kerkhove, WHO chief scientist Sylvie Briand, and Global Health Institute emeritus director Antoine Flahault. Negotiations involve northern and southern member states and major pharmaceutical firms.
Timeline of Recent Developments
- 1 May 2026 – Talks extended.
- Early May 2026 – Saturday deadline to finalise annex.
- 18–23 May 2026 – WHA session to consider annex; ratification possible at May 2027 assembly.
Why the PABS System Matters
The PABS system would enable early detection of new pathogens and guarantee that vaccines, tests and treatments derived from shared data reach all countries. Without it, the Pandemic Agreement lacks its core mechanism, weakening coordinated response and sustaining access gaps.
Official Statements & Responses
WHO leadership urged swift consensus, warning that another pandemic is inevitable. Van Kerkhove said legal work is needed to operationalise the PABS system; Briand cautioned that an unresolved annex could erode multilateral health governance. Northern states favour voluntary benefit-sharing, while southern states tie data sharing to assured vaccine access.
Criticism & Opposition
Southern nations say they will share pathogen samples only if compensation—mainly vaccines and treatments—is guaranteed. Northern countries, home to large pharmaceutical firms, prefer voluntary benefit-sharing, a stance southern representatives view as inadequate. The dispute underscores broader equity and technology-transfer concerns after COVID-19.
Conflicting Reports & Gaps
The sources do not reveal the exact benefit-sharing terms under discussion nor list which countries have endorsed any proposal. The precise Saturday deadline and the annex’s detailed provisions remain unspecified.
Verbatim Quotes
- “a matter of when, not if.” — Tedros Adhanom Ghebreyesus, WHO Director-General
- “Where there is a will, there is a way. I continue to believe that a consensus on the annex is possible.” — Tedros Adhanom Ghebreyesus, WHO Director-General
- “Maria Van Kerkhove, WHO’s lead on epidemic and pandemic preparedness, stressed its importance: “The PABS system will enable early detection of new pathogens.” — Maria Van Kerkhove, WHO lead on epidemic and pandemic preparedness
- “They experienced the Covid-19 pandemic, during which they benefited from only limited generosity from the north. There were no technology transfers.” — Antoine Flahault, emeritus director, Global Health Institute
What’s Next
The WHA meeting 18–23 May 2026 will review PABS progress. If talks stall, members may seek an extension or a special 2026 session. Ratification could then be submitted to the WHO Assembly in May 2027.
